John B Buse

John B Buse

UNVERIFIED PROFILE

Are you John B Buse?   Register this Author

Register author
John B Buse

John B Buse

Publications by authors named "John B Buse"

Are you John B Buse?   Register this Author

100Publications

2022Reads

31Profile Views

Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials.

Diabetes Obes Metab 2019 Jul 2;21(7):1745-1751. Epub 2019 Apr 2.

Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13698DOI Listing
July 2019

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.

Lancet Diabetes Endocrinol 2019 Jul 9;7(7):528-539. Epub 2019 Jun 9.

Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(19)30194-9DOI Listing
July 2019

Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting.

Diabetes Care 2019 Jun;42(6):e89-e91

Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc18-1609DOI Listing
June 2019

Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example.

Diabetes Obes Metab 2019 Jun 5. Epub 2019 Jun 5.

Department of Health Sciences, Diabetes Research Centre, University of Leicester, Leicester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13804DOI Listing
June 2019

Initial injectable therapy in type 2 diabetes: key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin.

Metabolism 2019 Jun 27. Epub 2019 Jun 27.

University of North Carolina, Chapel Hill, North, Carolina, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.metabol.2019.06.012DOI Listing
June 2019

Sodium-glucose co-transporter-2 inhibitor use and risk of lower-extremity amputation: Evolving questions, evolving answers.

Diabetes Obes Metab 2019 May 4;21(5):1223-1236. Epub 2019 Mar 4.

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13647DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459697PMC
May 2019

Study design choices for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type-2 diabetes.

Diabetes Obes Metab 2019 May 14. Epub 2019 May 14.

Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13774DOI Listing
May 2019

Glucose transporter inhibitor-conjugated insulin mitigates hypoglycemia.

Proc Natl Acad Sci U S A 2019 May 16;116(22):10744-10748. Epub 2019 May 16.

Department of Bioengineering, University of California, Los Angeles, CA 90095;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1901967116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561193PMC
May 2019

Evidence supports prediabetes treatment.

Science 2019 04;364(6438):341-342

Division of Endocrinology and Diabetes, University of Virginia, Charlottesville, VA 22903, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aax3548DOI Listing
April 2019

Health-related quality of life in people with type 2 diabetes participating in the LEADER trial.

Diabetes Obes Metab 2019 Mar 25;21(3):525-532. Epub 2018 Oct 25.

Nuffield Department of Population Health, Health Economics Research Centre, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587748PMC
March 2019

Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System.

Diabetes Care 2019 02 7;42(2):e21-e23. Epub 2018 Dec 7.

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc18-1893DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341287PMC
February 2019

Identifying individual risk rare variants using protein structure guided local tests (POINT).

PLoS Comput Biol 2019 02 19;15(2):e1006722. Epub 2019 Feb 19.

Department of Statistics, North Carolina State University, Raleigh, North Carolina, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pcbi.1006722DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396946PMC
February 2019

Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator.

Sci Transl Med 2019 Jan;11(475)

vTv Therapeutics Inc. and vTv Therapeutics LLC, High Point, NC 27265, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.aau3441DOI Listing
January 2019

Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial.

Diabetes Obes Metab 2018 12 10;20(12):2885-2893. Epub 2018 Oct 10.

Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13545DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231963PMC
December 2018

Liraglutide and Glycaemic Outcomes in the LEADER Trial.

Diabetes Ther 2018 Dec 3;9(6):2383-2392. Epub 2018 Nov 3.

University of North Carolina School of Medicine, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s13300-018-0524-z
Publisher Site
http://dx.doi.org/10.1007/s13300-018-0524-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250637PMC
December 2018

Advances in transdermal insulin delivery.

Adv Drug Deliv Rev 2018 Dec 8. Epub 2018 Dec 8.

Department of Bioengineering, University of California, Los Angeles, CA 90095, USA; Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695, USA; California NanoSystems Institute, Jonsson Comprehensive Cancer Center, Center for Minimally Invasive Therapeutics, University of California, Los Angeles, CA 90095, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.addr.2018.12.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556146PMC
December 2018

Impact of metformin use on the cardiovascular effects of dipeptidyl peptidase-4 inhibitors: An analysis of Medicare claims data from 2007 to 2015.

Diabetes Obes Metab 2018 Nov 20. Epub 2018 Nov 20.

Department of Medicine, Division of Endocrinology and Metabolism, University of North Carolina, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13589DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527500PMC
November 2018

Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults.

Diabetes Care 2018 09 16;41(9):1998-2009. Epub 2018 Jul 16.

Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc17-2285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105327PMC
September 2018

Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol.

Diabetes Technol Ther 2018 09 21;20(9):571-575. Epub 2018 Aug 21.

5 Children's and Youth Hospital Auf der Bult , Hannover Medical School, Hannover, Germany .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/dia.2018.0246DOI Listing
September 2018

Hypoglycemia, Cardiovascular Outcomes, and Death: The LEADER Experience.

Diabetes Care 2018 08 14;41(8):1783-1791. Epub 2018 Jun 14.

University of North Carolina School of Medicine, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc17-2677DOI Listing
August 2018

Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes?

Diabetes Care 2018 08 25;41(8):1560-1562. Epub 2018 Jun 25.

Division of Endocrinology, Diabetes & Clinical Nutrition, Oregon Health & Science University, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dci18-0025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054497PMC
August 2018

Calendar time as an instrumental variable in assessing the risk of heart failure with antihyperglycemic drugs.

Pharmacoepidemiol Drug Saf 2018 08 26;27(8):857-866. Epub 2018 Jun 26.

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapell Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.4578DOI Listing
August 2018

Primum Non Nocere: Refocusing Our Attention on Severe Hypoglycemia Prevention.

Diabetes Care 2018 08;41(8):1557-1559

Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC

View Article

Download full-text PDF

Source
http://care.diabetesjournals.org/lookup/doi/10.2337/dci18-00
Publisher Site
http://dx.doi.org/10.2337/dci18-0020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054498PMC
August 2018

Management of Type 1 Diabetes With a Very Low-Carbohydrate Diet: A Word of Caution.

Pediatrics 2018 08;142(2)

Chief, Division of Endocrinology and Metabolism, Department of Medicine, University of North Carolina at Chapel Hill.

View Article

Download full-text PDF

Source
http://pediatrics.aappublications.org/lookup/doi/10.1542/ped
Publisher Site
http://dx.doi.org/10.1542/peds.2018-1536BDOI Listing
August 2018

The Risk of Acute Pancreatitis After Initiation of Dipeptidyl Peptidase 4 Inhibitors: Testing a Hypothesis of Subgroup Differences in Older U.S. Adults.

Diabetes Care 2018 06 4;41(6):1196-1203. Epub 2018 Apr 4.

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc17-2212DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961396PMC
June 2018

Myocardial Infarction Subtypes in Patients With Type 2 Diabetes Mellitus and the Effect of Liraglutide Therapy (from the LEADER Trial).

Am J Cardiol 2018 06 15;121(12):1467-1470. Epub 2018 Mar 15.

Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2018.02.030DOI Listing
June 2018

Bioresponsive Microneedles with a Sheath Structure for H O and pH Cascade-Triggered Insulin Delivery.

Small 2018 04 26;14(14):e1704181. Epub 2018 Feb 26.

Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC, 27695, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/smll.201704181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053064PMC
April 2018

Core-Shell Microneedle Gel for Self-Regulated Insulin Delivery.

ACS Nano 2018 03 19;12(3):2466-2473. Epub 2018 Feb 19.

Joint Department of Biomedical Engineering , University of North Carolina at Chapel Hill and North Carolina State University , Raleigh , North Carolina 27695 , United States.

View Article

Download full-text PDF

Source
http://pubs.acs.org/doi/10.1021/acsnano.7b08152
Publisher Site
http://dx.doi.org/10.1021/acsnano.7b08152DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037424PMC
March 2018

Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes.

Diabetes Obes Metab 2018 01 8;20(1):129-140. Epub 2017 Aug 8.

Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13049DOI Listing
January 2018

Synthetic beta cells for fusion-mediated dynamic insulin secretion.

Nat Chem Biol 2018 Jan 30;14(1):86-93. Epub 2017 Oct 30.

Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nchembio.2511DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053053PMC
January 2018

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.

N Engl J Med 2017 12 13;377(24):2337-2348. Epub 2017 Sep 13.

From the University of Colorado Denver, Aurora (S.K.G.); the University of California at San Diego, San Diego (R.R.H.); Lexicon Pharmaceuticals, The Woodlands (P.B., D.G.-P., P.L., P.S.), the University of Texas Southwestern Medical Center, Dallas (D.K.M.), and Baylor College of Medicine and Texas Children's Hospital, Houston (J.A.K.) - all in Texas; the Diabetes Research Center, University of North Carolina School of Medicine, Durham (J.B.B.); the University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, United Kingdom (M.J.D.); the University of Sydney, Sydney (G.R.F.); University Campus Bio-Medico of Rome, Rome (P.P.); Vall d'Hebron Research Institute, Barcelona, and CIBERDEM-Instituto de Salud Carlos III, Madrid (R.S.); Diabetes Center Auf der Bult, Hannover Medical School, Hannover, Germany (T.D.); and the University of Southern California, Los Angeles (A.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1708337DOI Listing
December 2017

Metformin Use May Moderate the Effect of DPP-4 Inhibitors on Cardiovascular Outcomes.

Diabetes Care 2017 12 19;40(12):1787-1789. Epub 2017 Oct 19.

Division of Endocrinology & Metabolism, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc17-1528DOI Listing
December 2017

Concerns About Conclusions of Self-monitoring of Blood Glucose-Reply.

JAMA Intern Med 2017 12;177(12):1874-1875

Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamainternmed.2017.6152DOI Listing
December 2017

Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin.

Hypertension 2017 11 28;70(5):907-914. Epub 2017 Aug 28.

From the Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.M.N., D.S.G., Y.L., J.B.G., E.D.P.); Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.K.M.); Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada (P.W.A.); Division of Endocrinology, University of North Carolina School of Medicine, Chapel Hill (J.B.B.); Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ (S.S.E.); The George Washington University Biostatistics Center, Rockville, MD (J.M.L.); Munich Diabetes Research Institute, Helmholtz Center, Germany (E.S.); Department of Cardiovascular Sciences, University of Leuven, Belgium (F.V.d.W.); and Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Churchill Hospital, United Kingdom (R.R.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638706PMC
November 2017

Safety of Degludec versus Glargine in Type 2 Diabetes.

N Engl J Med 2017 11;377(20):1995-1996

University of North Carolina School of Medicine, Chapel Hill, NC

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1712575DOI Listing
November 2017

Liraglutide and Renal Outcomes in Type 2 Diabetes.

N Engl J Med 2017 11;377(22):2197-2198

University of North Carolina School of Medicine, Chapel Hill, NC

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1713042DOI Listing
November 2017

The War Is Not Yet Won.

Diabetes Care 2017 09;40(9):1152-1153

University of North Carolina School of Medicine, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dci17-0008DOI Listing
September 2017

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.

N Engl J Med 2017 09 14;377(13):1228-1239. Epub 2017 Sep 14.

From the Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford (R.R.H., M.A.B.), and the International Centre for Circulatory Health, Imperial College London, London (N.P.) - both in the United Kingdom; Duke Clinical Research Institute, Duke University School of Medicine, Durham (R.J.M., V.P.T., Y.L., N.J.P., A.F.H.), and the Division of Endocrinology, University of North Carolina School of Medicine, Chapel Hill (J.B.B.) - both in North Carolina; the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong (J.C.C.); AstraZeneca Research and Development, Gaithersburg, MD (J.C., S.M.G., N.I., P.Ö.); Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Research Center, Florence, Italy (A.P.M.); the Department of Cardiology, University of Texas Southwestern Medical Center, Dallas (S.P.M.); the India Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India (A.R.); and the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and University of Toronto, Toronto (B.Z.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1612917DOI Listing
September 2017

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

N Engl J Med 2017 08 12;377(8):723-732. Epub 2017 Jun 12.

From the Research Medical Center, Kansas City, MO (S.P.M.); University of Texas Southwestern Medical Center, Dallas (D.K.M.); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto (B.Z.); Imperial Clinical Trials Unit, Imperial College London, London (N.R.P.); University of Washington, Seattle (S.S.E.); Medical University of Graz, Graz, Austria (T.R.P.); Florida Hospital Translational Research Institute for Metabolism and Diabetes and Sanford Burnham Prebys Medical Discovery Institute, Orlando (R.E.P.); Novo Nordisk, Søborg, Denmark (P.-M.H., M.L., K.B.-F., A.M., S.S., K.K.); and University of North Carolina School of Medicine, Chapel Hill (J.B.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1615692DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731244PMC
August 2017

Liraglutide and Renal Outcomes in Type 2 Diabetes.

N Engl J Med 2017 08;377(9):839-848

From KfH Kidney Center, Munich, and Friedrich Alexander University of Erlangen, Erlangen - both in Germany (J.F.E.M.); Novo Nordisk, Bagsvaerd, Denmark (D.D.Ø., K.B.-F., S.R., K.T.); University of Texas Southwestern Medical Center, Dallas (S.P.M.); Imperial College London, London (N.R.P.); Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto, Toronto (B.Z.); and University of North Carolina School of Medicine, Chapel Hill (J.B.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1616011DOI Listing
August 2017

A survey of practices for the use of electronic health records to support research recruitment.

J Clin Transl Sci 2017 Aug;1(4):246-252

NC Translational and Clinical Sciences Institute, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/cts.2017.301DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890320PMC
August 2017

No increased risk of cardiovascular events in older adults initiating dipeptidyl peptidase-4 inhibitors vs therapeutic alternatives.

Diabetes Obes Metab 2017 07 17;19(7):970-978. Epub 2017 Mar 17.

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.12906DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471114PMC
July 2017

Differential Use of Screening Mammography in Older Women Initiating Metformin versus Sulfonylurea.

Pharmacoepidemiol Drug Saf 2017 Jun 29;26(6):666-675. Epub 2017 Mar 29.

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.4195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457352PMC
June 2017

Comparative Effect of Initiating Metformin Versus Sulfonylureas on Breast Cancer Risk in Older Women.

Epidemiology 2017 05;28(3):446-454

aDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC; bDepartment of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; and cDepartment of Radiology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/EDE.0000000000000635DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378597PMC
May 2017

Red Blood Cells for Glucose-Responsive Insulin Delivery.

Adv Mater 2017 May 7;29(18). Epub 2017 Mar 7.

Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC, 27695, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/adma.201606617
Publisher Site
http://dx.doi.org/10.1002/adma.201606617DOI Listing
May 2017

Insulin-Responsive Glucagon Delivery for Prevention of Hypoglycemia.

Small 2017 05 20;13(19). Epub 2017 Mar 20.

Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC, 27695, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/smll.201603028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769873PMC
May 2017

Three approaches to glucose monitoring in non-insulin treated diabetes: a pragmatic randomized clinical trial protocol.

BMC Health Serv Res 2017 05 25;17(1):369. Epub 2017 May 25.

Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12913-017-2202-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445357PMC
May 2017

Hypoxia and HO Dual-Sensitive Vesicles for Enhanced Glucose-Responsive Insulin Delivery.

Nano Lett 2017 02 12;17(2):733-739. Epub 2017 Jan 12.

Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University , Raleigh, North Carolina 27695, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.nanolett.6b03848DOI Listing
February 2017

HO-Responsive Vesicles Integrated with Transcutaneous Patches for Glucose-Mediated Insulin Delivery.

ACS Nano 2017 01 4;11(1):613-620. Epub 2017 Jan 4.

Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University , Raleigh, North Carolina 27695, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsnano.6b06892DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568789PMC
January 2017

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:
John B Buse

N Engl J Med 2016 11;375(18):1798-9

University of North Carolina, Chapel Hill, NC

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1611289DOI Listing
November 2016

Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response.

Front Genet 2016 17;7:138. Epub 2016 Aug 17.

Department of Statistics, North Carolina State UniversityRaleigh, NC, USA; Bioinformatics Research Center, North Carolina State UniversityRaleigh, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fgene.2016.00138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013254PMC
August 2016